Noida Extension, based Yatharth Hospital proudly inaugurated its new Cancer & Radiation Oncology Centre, marking a significant milestone in redefining cancer care services across Delhi-NCR and India. Equipped with cutting-edge technology and comprehensive facilities, including a Linear Accelerator (Elekta Versa HD), Brachytherapy, and PET-CT Scan capabilities, the Centre aims to revolutionize cancer treatment.

The inauguration ceremony, held on Sunday, witnessed the presence of esteemed dignitaries, with Dr. Sunil Kumar Sharma, CMO of Gautam Buddh Nagar, serving as the chief guest. Dr. Ajay Tyagi, Chairman, Yatharth Group of Hospitals, and Dr. Kapil Tyagi, Managing Director, Yatharth Group of Hospitals, graced the occasion alongside renowned speakers and doctors from the oncology department.

Speaking about the new facility, Mr. Yatharth Tyagi, Director of Yatharth Group of Hospitals, expressed his enthusiasm, stating, "At Yatharth, we prioritize the well-being of our patients above all else. The inauguration of our Cancer & Radiation Oncology Centre marks a significant step towards our commitment to healthcare excellence. Through continuous improvement and research, we strive to deliver compassionate and comprehensive care to every individual we serve."

Dr. (Prof.) Sudarsan De, Group Director-Radiation Oncology, emphasized the Centre's dedication to leveraging advanced technologies for precise and effective cancer treatments. "With state-of-the-art equipment like the Elekta Versa HD Linear Accelerator, we aim to elevate the standards of oncology care in India," he remarked.

Dr. Malay Nandy, Group Director-Haemato-Medical Oncology, underscored the hospital's multidisciplinary approach to cancer treatment, focusing on personalized care tailored to each patient's needs. He highlighted the importance of early diagnosis and treatment through "high degree of suspicion and biopsy" to achieve high cure rates.

With a team of experienced oncologists and specialized staff, Yatharth Hospital aims to emerge as a leader in cancer care, offering a comprehensive range of treatment modalities. From chemotherapy and targeted therapy to immunotherapy, radiation therapy, and surgical interventions, the Centre is committed to advancing healthcare delivery